You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 85 No. 2, FEBRUARY 1950 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

CHLORAMPHENICOL IN TREATMENT OF EBERTHELLA TYPHOSA G OSTEOMYELITIS

Report of a Case

CHESTER W. MORSE, M.D.; FRANK M. GEISER, M.D.

Arch Intern Med. 1950;85(2):280-283.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THIS CASE is reported because of the rarity of the type G typhoid bacillus, the infrequency of typhoid osteomyelitis in the United States and the promising status of chloramphenicol (chloromycetin®) in treatment of patients with typhoid infections.

REPORT OF CASE

History.

—R. C. was a 27 year old man who first presented himself at the infirmary at Emory University in March 1948, because of recurrent attacks of pain in the right shoulder. During the war he had served as a Royal Air Force pilot and had been stationed in Eastern Canada, the United States, Great Britain, Spain, Gibraltar, France, Malta, French Morocco, Algeria, Tunisia, Cyprus, Palestine, Iraq, Iran, India, Ceylon, Saudi Arabia and Egypt. From July 1946 until the time of writing he had been residing in southeastern United States. He had received his first immunization against typhoid in 1940 and continued booster shots at yearly intervals. It is surmised . . . [Full Text PDF of this Article]


Author Affiliations

EMORY UNIVERSITY, GA.

From the Student Health Service, Emory University, and Emory University School of Medicine, Atlanta.


Footnotes

Parke, Davis & Company supplied the drug used in this study.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1950 American Medical Association. All Rights Reserved.